<sentence id="0">High-mannose-specific deglycosylation of HIV-1 gp120 induced by resistance to cyanovirin-N and the impact on antibody neutralization .</sentence>
<sentence id="1">HIV-1 uses glycans on gp120 to occlude its highly immunogenic epitopes .</sentence>
<sentence id="2">To better elucidate escape mechanisms of HIV-1 from carbohydrate-binding agents ( CBA ) and to understand the impact of CBA-escape on viral immune evasion , we generated and examined the biological properties of HIV-1 resistant to cyanovirin-N ( CV-N ) or cross-resistant to additional CBAs .</sentence>
<sentence id="3">Genotypic and phenotypic characterization of resistant env clones <scope type="spec" id="0"> <cue type="spec" id="0">indicated that</cue> 3-5 high-mannose residues from 289 to 448 in the C2-C4 region of gp120 were mutated and correlated with the resistance levels</scope> .</sentence>
<sentence id="4">The specificity and minimal requirements of deglycosylation for CV-N resistance were further assessed by mutagenesis study .</sentence>
<sentence id="5">The sensitivity of resistant variants to a range of CBAs , immunoglobulins , sera and monoclonal antibodies ( MAb ) were investigated .</sentence>
<sentence id="6">For the first time , our data have collectively defined the high-mannose residues on gp120 affecting CV-N activity , and demonstrated that CBA-escape HIV-1 has increased sensitivity to immunoglobulins and sera from HIV patients , and particularly to V3 loop-directed MAbs .</sentence>
<sentence id="7">Our study provides a proof-of-concept that targeting HIV-1 glycan shields <scope type="spec" id="1"> <cue type="spec" id="1">may</cue> represent a novel antiviral strategy</scope> .</sentence>